A health economics evaluation assists companies during product development to better understand the product’s impact across the ecosystem and position it appropriately.
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
Alira Health Published in Business Development & Licensing Journal
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from(...)
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)
Our Parallel Trade Expertise
Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.
Digital Health Platform Strategy for the Management of Chronic Respiratory Conditions
When our client wanted to explore the potential of digital health in the management of chronic respiratory conditions, Alira Health stepped in to help the client fully understand the opportunity.
Alira Health Starts a New Collaboration with Mark Inigo Jones on Parallel Trade Management
We are pleased to announce a new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.